Zhi‐Ming Shao

14.4k total citations · 4 hit papers
222 papers, 8.6k citations indexed

About

Zhi‐Ming Shao is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Zhi‐Ming Shao has authored 222 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Oncology, 101 papers in Cancer Research and 89 papers in Molecular Biology. Recurrent topics in Zhi‐Ming Shao's work include Breast Cancer Treatment Studies (70 papers), HER2/EGFR in Cancer Research (37 papers) and Breast Lesions and Carcinomas (29 papers). Zhi‐Ming Shao is often cited by papers focused on Breast Cancer Treatment Studies (70 papers), HER2/EGFR in Cancer Research (37 papers) and Breast Lesions and Carcinomas (29 papers). Zhi‐Ming Shao collaborates with scholars based in China, United States and United Kingdom. Zhi‐Ming Shao's co-authors include Ke‐Da Yu, Zhen‐Zhou Shen, Jiong Wu, Lei Fan, Sanford H. Barsky, Dianne M. Finkelstein, Paul E. Goss, Jun-Jie Li, Kathrin Strasser‐Weippl and Jessica St. Louis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Zhi‐Ming Shao

214 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast cancer in China

2014 1.1k citations Ke‐Da Yu, Zhi‐Ming Shao et al. profile →
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

2022 383 citations Xi Jin, Ding Ma et al. profile →
Breast cancer: pathogenesis and treatments

2025 145 citations Zhi‐Ming Shao, Ke‐Da Yu et al. profile →
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential

2024 96 citations Zhi‐Ming Shao et al. profile →

Peers

Countries citing papers authored by Zhi‐Ming Shao

Since Specialization

Citations

This map shows the geographic impact of Zhi‐Ming Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Ming Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Ming Shao more than expected).

Fields of papers citing papers by Zhi‐Ming Shao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Ming Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Ming Shao. The network helps show where Zhi‐Ming Shao may publish in the future.

Co-authorship network of co-authors of Zhi‐Ming Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Ming Shao. A scholar is included among the top collaborators of Zhi‐Ming Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Ming Shao. Zhi‐Ming Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mitigating methane emissions: Analyzing the microstructural evolution of Pd-based membranes under lean methane oxidation conditions 2025 ·Fuel ·(unknown), Baisheng Nie, (unknown), Liangliang Jiang, Zhi‐Ming Shao, Jijiang Huang	0
2	Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey 2025 ·European Journal of Surgical Oncology ·Bingqiu Xiu, Qi Zhang, (unknown), Shuang Hao, Benlong Yang, Junjie Li, Zhi‐Ming Shao, Jiong Wu	0
3	Multiomics and single‐cell sequencings reveal the specific biological characteristics of low Ki‐67 triple‐negative breast cancer 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Zhi‐Ming Shao, Hong Ling, Xin Hu	1
4	SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC 2024 ·Advanced Science ·Qiaodan Deng, (unknown), Cuicui Liu, (unknown), Juchuanli Tu, Xue‐Yan He, Jie Xia, (unknown), Siqin Li, Xian Chen, W. F. Mader, Lu Zhang, Yizhou Jiang, Zhi‐Ming Shao, Ceshi Chen, Suling Liu, Jiahui Xu, (unknown), (unknown)	1
5	Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors 2023 ·Cancer Communications ·(unknown), Bin Li, Ye Wang, Juan Jin, Yu Yang, Leihuan Huang, (unknown), Jian Zhang, Biyun Wang, Zhi‐Ming Shao, Ting Ni, Shenglin Huang, Xichun Hu, Zhonghua Tao	8
6	Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer 2022 ·Cell Reports ·(unknown), Yi‐Zhou Jiang, Chen Shao, Wenting Peng, Mingwei Liu, Da‐Qiang Li, (unknown), Peng Du, Yin Huang, Feifei Li, (unknown), (unknown), Xi Jin, Ding Ma, Yi Xiao, Pengyuan Yang, Jun Qin, Zhi‐Ming Shao, Weimin Zhu	37
7	PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer 2021 ·Cancer Research ·Tian‐Jian Yu, Yingying Liu, Xiaoguang Li, Bi Lian, Xun‐Xi Lu, Xi Jin, Zhi‐Ming Shao, Xin Hu, Gen‐Hong Di, Yi‐Zhou Jiang	32
8	Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer 2021 ·Nature Cancer ·Minhong Shen, Heath A. Smith, Yong Wei, Yi‐Zhou Jiang, Sheng Zhao, (unknown), Michelle Rowicki, Yong Tang, Xiang Hang, Song‐Yang Wu, Liling Wan, Zhi‐Ming Shao, Yibin Kang	45
9	GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer 2021 ·Journal for ImmunoTherapy of Cancer ·Jinli Wei, Siyu Wu, Yun‐Song Yang, Yi Xiao, Xi Jin, Xiao‐En Xu, Xin Hu, Da‐Qiang Li, Yi‐Zhou Jiang, Zhi‐Ming Shao	41
10	Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer 2018 ·Cancer Research ·(unknown), (unknown), (unknown), Rui Sun, (unknown), Zhi‐Ming Shao, Da‐Qiang Li	80
11	A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients 2016 ·Scientific Reports ·Xi Jin, Yi-Zhou Jiang, Sheng Chen, Zhi‐Ming Shao, Gen‐Hong Di	22
12	Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype 2015 ·Oncotarget ·Ke‐Da Yu, Yi-Zhou Jiang, Zhi‐Ming Shao	8
13	Favorable Prognostic Impact in Loss of TP53 and PIK3CA Mutations after Neoadjuvant Chemotherapy in Breast Cancer 2014 ·Cancer Research ·Yi-Zhou Jiang, Ke‐Da Yu, Jing Bao, (unknown), Zhi‐Ming Shao	35
14	Clinical and Pathological Response to Neoadjuvant Chemotherapy Based on Primary Tumor Reduction is Correlated to Survival in Hormone Receptor-Positive but not Hormone Receptor-Negative Locally Advanced Breast Cancer 2014 ·Annals of Surgical Oncology ·Sheng Chen, Yin Liu, (unknown), Liang Huang, (unknown), Zhi‐Ming Shao	21
15	Different Patterns in the Prognostic Value of Age for Breast Cancer-Specific Mortality Depending on Hormone Receptor Status: A SEER Population-Based Analysis 2014 ·Annals of Surgical Oncology ·Yi‐Rong Liu, Yi-Zhou Jiang, Ke‐Da Yu, Zhi‐Ming Shao	26
16	Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer 2013 ·Clinical Cancer Research ·Ke‐Da Yu, Rui Zhu, Ming Zhan, Angel Rodriguez, Wei Yang, (unknown), Andreas Makris, Brian D. Lehmann, Xi Chen, Ingrid A. Mayer, Jennifer A. Pietenpol, Zhi‐Ming Shao, W. Fraser Symmans, Jenny C. Chang	127
17	The Residual Tumor Autophagy Marker LC3B Serves as a Prognostic Marker in Local Advanced Breast Cancer after Neoadjuvant Chemotherapy 2013 ·Clinical Cancer Research ·Sheng Chen, Yi-Zhou Jiang, Liang Huang, Ruoji Zhou, Ke‐Da Yu, Yin Liu, Zhi‐Ming Shao	65
18	Association of HER-2 Copy Number and HER-2/CEP-17 Ratio with Neoadjuvant Taxane-Containing Chemotherapy Sensitivity in Locally Advanced Breast Cancer 2012 ·The Oncologist ·Ke‐Da Yu, Guang‐Yu Liu, Xiao-Yan Zhou, Ying Zhou, Jiong Wu, (unknown), Zhen‐Zhou Shen, Zhi‐Ming Shao	7
19	Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient Survival 2009 ·Clinical Cancer Research ·(unknown), Zhou-Luo Ou, (unknown), Zhen‐Zhou Shen, Zhi‐Ming Shao	76
20	Enhanced Expression of Rab27A Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II 2008 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), Zhen‐Zhou Shen, Zhi‐Ming Shao	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact